Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck

Head and Neck

Volumn 28, Issue 3, 2006, Pages 244-248

  Southwell, Katherine E ^a   Chaplin, John M ^a   Eisenberg, Robert L ^a   McIvor, Nicholas P ^a   Morton, Randall P ^a  

^a NONE

Author keywords

Immunocompromise; Metastatic; Neck; Parotid; SCC

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MALE; MANDIBLE RESECTION; MANTLE CELL LYMPHOMA; MASTOIDECTOMY; NECK DISSECTION; NECK METASTASIS; NONHODGKIN LYMPHOMA; PAROTID GLAND CARCINOMA; PAROTIDECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TEMPORAL BONE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; LOGISTIC MODELS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEW ZEALAND; PAROTID GLAND; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 33144473397     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20321     Document Type: Article

References (8)

1. Freeman NR, Fourbrother GE, Rose RJ. Survey of skin cancer incidence in the Hamilton area. N Z Med J 1982;95:529-533.
2. Mihalov ML, Guttuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single centre. Clin Transplant 1996;10:248-2551.
3. Euvard S, Kanitakis J, Pouteil-Noble C, Disant F, Dureau G, Finaz de Villaine J, Claud A, Thivolet J. Aggressive squamous cell carcinoma in organ transplant recipients. Transplant Proc 1995;27:1767-1768.
4. Weatherall, Ledingham, Warrell. Oxford textbook of medicine, 3rd ed. vol 2. p 2257.
5. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002;24:417-422.
6. Levi F, Randimbison L, Tc VC, La Vecchia C. Non-Hodgkins lymphoma, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996;74:1847-1850.
7. Bennett MA, O'Grady A, Kay EW, Leader M, Murphy GM. p53 mutations in squamous cell carcinomas from renal transplant recipients. Biochem Soc Trans 1997;25:342-345.
8. Khorshid SM, Glover MT, Churchill L, McGregor JM, Proby CM. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours. J Cutan Pathol 1996;23:229-233.